Evidence map›Paper›PMID 36641638›Full record

ReviewAntioxidants & redox signaling2023

The Role of Oxidants in Percutaneous Coronary Intervention-Induced Endothelial Dysfunction: Can We Harness Redox Signaling to Improve Clinical Outcomes?

Kathryn Wolhuter, Stephanie M Y Kong, Christopher P Stanley, Jason C Kovacic

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Antioxidants & redox signaling, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Kathryn WolhuterVictor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia.ORCID 0000-0001-6293-9820
Stephanie M Y KongVictor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia.ORCID 0000-0001-6774-9575
Christopher P StanleyHeart Research Institute, University of Sydney, Sydney, Australia.ORCID 0000-0003-0875-7158
Jason C KovacicVictor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia.ORCID 0000-0003-4555-769X
Victor Chang Cardiac Research Institute · AUThe University of Sydney · AU

Funding

Understanding the Molecular Mechanisms of Fibromuscular DysplasiaR01HL148167 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KADIAN-DODOV, DANIELLA, KOVACIC, JASON CIRIL · 2020 to 2023
$2.8M
NHLBI NIH HHS R01 HL148167
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coronary Artery DiseasePercutaneous Coronary InterventionHumansOxidantsOxidation-ReductionTreatment OutcomeOxidantsCADendothelial dysfunctionoxidantsPCIredox signaling

Identifiers

PMID36641638
PMCPMC10402708
OpenAlexW4316253611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.